Paclitaxel Polymeric Micelles for Injection Versus TPC on the Treatment of HER2-negative Metastatic Breast Cancer (MBC).

Conditions: Metastatic Breast Cancer (MBC) Interventions: Drug: Paclitaxel Polymeric Micelles for Injection; Drug: Eribulin Mesilate injection; Drug: Capecitabine Tablets; Drug: Gemcitabine Hydrochloride for Injection; Drug: Vinorelbine Tartrate Injection; Drug: Paclitaxel (albumin-bound) Sponsors: Shanghai Yizhong Pharmaceutical Co., Ltd. Recruiting

https://clinicaltrials.gov/study/NCT06143553

Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials